Little Green Pharma Ltd. (AU:LGP) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Little Green Pharma Ltd. announces the anticipated shift in US cannabis regulation, as the DEA is set to reclassify cannabis from Schedule I to Schedule III, acknowledging its medical benefits and potentially easing tax burdens on operators. This regulatory milestone, coupled with recent legalization in Germany, has sparked a surge in North American cannabis stocks, with ETFs reflecting the industry seeing over a 25% increase. Such developments are expected to positively impact other cannabis firms, including Little Green Pharma, as market trends suggest a correlation with North American market movements.
For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.